Frontlight ResearchEarly access
Peripheral artery disease trials in Finland
1 of 2 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleSafety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-threatening Ischemia
- Where
- Helsinki, Tampere, Turku
- Age
- 18 years to 85 years
- People
- 42
- Run by
- Aplagon Oy
See details and how to joinNCT07352800 · EU 2025-522390-11-00